MX2010003892A - Polipeptidos modificados de la hormona del crecimiento. - Google Patents

Polipeptidos modificados de la hormona del crecimiento.

Info

Publication number
MX2010003892A
MX2010003892A MX2010003892A MX2010003892A MX2010003892A MX 2010003892 A MX2010003892 A MX 2010003892A MX 2010003892 A MX2010003892 A MX 2010003892A MX 2010003892 A MX2010003892 A MX 2010003892A MX 2010003892 A MX2010003892 A MX 2010003892A
Authority
MX
Mexico
Prior art keywords
growth hormone
modified growth
hormone polypeptides
proteins
treatment
Prior art date
Application number
MX2010003892A
Other languages
English (en)
Spanish (es)
Inventor
Peter Artymiuk
Jon Sayers
Richard A Ross
Original Assignee
Asterion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asterion Ltd filed Critical Asterion Ltd
Publication of MX2010003892A publication Critical patent/MX2010003892A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2010003892A 2007-10-10 2008-09-10 Polipeptidos modificados de la hormona del crecimiento. MX2010003892A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97901007P 2007-10-10 2007-10-10
GBGB0719818.7A GB0719818D0 (en) 2007-10-11 2007-10-11 Growth hormone fusion polypeptides
PCT/GB2008/003056 WO2009047474A2 (en) 2007-10-10 2008-09-10 Modified growth hormone polypeptides

Publications (1)

Publication Number Publication Date
MX2010003892A true MX2010003892A (es) 2010-05-17

Family

ID=38787949

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003892A MX2010003892A (es) 2007-10-10 2008-09-10 Polipeptidos modificados de la hormona del crecimiento.

Country Status (17)

Country Link
US (2) US8273552B2 (cg-RX-API-DMAC7.html)
EP (2) EP2886553A1 (cg-RX-API-DMAC7.html)
JP (1) JP5697983B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100067686A (cg-RX-API-DMAC7.html)
CN (1) CN101932600B (cg-RX-API-DMAC7.html)
AR (1) AR068038A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008309386A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818639A2 (cg-RX-API-DMAC7.html)
CA (1) CA2701369A1 (cg-RX-API-DMAC7.html)
DK (1) DK2209798T3 (cg-RX-API-DMAC7.html)
ES (1) ES2532600T3 (cg-RX-API-DMAC7.html)
GB (1) GB0719818D0 (cg-RX-API-DMAC7.html)
IL (1) IL203073A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010003892A (cg-RX-API-DMAC7.html)
RU (1) RU2471808C2 (cg-RX-API-DMAC7.html)
TW (1) TW200918098A (cg-RX-API-DMAC7.html)
WO (1) WO2009047474A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606946D0 (en) * 2006-04-06 2006-05-17 Asterion Ltd Polypeptide antagonist
GB201104285D0 (en) 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds
CA2447632C (en) * 2000-06-16 2011-08-02 Asterion Limited Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor
ATE509097T1 (de) 2001-11-21 2011-05-15 Us Health Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
WO2004090135A2 (en) 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
MX2007001180A (es) * 2004-07-26 2007-04-13 Asterion Ltd Enlazantes.
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
EP2288386A1 (en) * 2008-02-19 2011-03-02 Asterion Limited Modified linkers

Also Published As

Publication number Publication date
CN101932600A (zh) 2010-12-29
CN101932600B (zh) 2014-05-28
BRPI0818639A2 (pt) 2015-04-07
AR068038A1 (es) 2009-10-28
EP2209798A2 (en) 2010-07-28
WO2009047474A2 (en) 2009-04-16
CA2701369A1 (en) 2009-04-16
US20100197589A1 (en) 2010-08-05
US8273552B2 (en) 2012-09-25
JP5697983B2 (ja) 2015-04-08
IL203073A0 (en) 2010-11-30
WO2009047474A3 (en) 2010-09-02
GB0719818D0 (en) 2007-11-21
JP2011507487A (ja) 2011-03-10
ES2532600T3 (es) 2015-03-30
DK2209798T3 (en) 2015-03-23
KR20100067686A (ko) 2010-06-21
TW200918098A (en) 2009-05-01
US20120322735A1 (en) 2012-12-20
EP2209798B1 (en) 2014-12-31
EP2886553A1 (en) 2015-06-24
AU2008309386A1 (en) 2009-04-16
RU2471808C2 (ru) 2013-01-10
RU2010103159A (ru) 2011-11-20

Similar Documents

Publication Publication Date Title
WO2010020766A3 (en) Interleukin fusion polypeptides
JOP20190083B1 (ar) بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
MX2024005946A (es) Polipeptidos que se unen al componente del complemento c5 o albumina serica y proteinas de fusion de los mismos.
UA113609C2 (xx) Антигензв'язуючий білок, який зв'язує людський il-23
PH12016500081A1 (en) Immunoglobulin variants and uses thereof
WO2009013461A8 (en) Growth hormone fusion proteins
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
MX2011013903A (es) Polipeptidos quimericos y usos de los mismos.
WO2006048777A3 (en) Modified growth hormones
PH12019500596A1 (en) Recombinant binding proteins and their use
NZ603570A (en) Biological materials related to her3
SG196839A1 (en) Antibodies against fcrn and use thereof
PH12013500410B1 (en) Vegf-binding molecules
MX2009009200A (es) Tratamiento de enfermedades caracterizadas por la inflamacion.
EA201001223A1 (ru) Стабилизированные белковые композиции
MX2010008206A (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf.
MX2007009807A (es) Agentes terapeuticos de aptameros utiles en el tratamiento de trastornos relacionados con el complemento.
WO2008140493A3 (en) Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
EP2102355A4 (en) PROTEINS AND PEPTIDES WITH EXTENDED ACTION AND METHODS OF PRODUCTION AND USE THEREOF
WO2006104913A3 (en) USE OF ANTI-TNF OR ANTI-ILl RNAI TO SUPPRESS PRO- INFLAMMATORY CYTOKINE ACTIONS LOCALLY TO TREAT PAIN
MY206284A (en) Anti-cd63 antibodies, conjugates, and uses thereof
MX2008012748A (es) Un proceso para la concentracion de un polipeptido.
MX2011004483A (es) Leucolectinas y sus usos.
MX2016000393A (es) Modificaciones de proteinas quimioenzimaticas de lisina utilizando transglutaminasa microbiana.
UA101814C2 (ru) Фактор, задействованный в латентной инфекции герпесвирусом, и его применение

Legal Events

Date Code Title Description
FA Abandonment or withdrawal